Estrategias Combinadas en Inmunoterapia Traslacional
ITC
![Foto de Estrategias Combinadas en Inmunoterapia Traslacional](/img/uploaded/479403294d9802387805dfa0a2918bd0.jpg)
![Foto de Aarhus University Hospital](/img/noimage_org.png)
Aarhus University Hospital
Århus, DinamarcaPublicaciones en colaboración con investigadores/as de Aarhus University Hospital (2)
2017
-
Predictors of responses to immune checkpoint blockade in advanced melanoma
Nature Communications, Vol. 8, Núm. 1
-
Results from an integrated safety analysis of urelumab, an agonist anti-CD137 monoclonal antibody
Clinical Cancer Research, Vol. 23, Núm. 8, pp. 1929-1936